Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03GII
|
||||
Former ID |
DIB001670
|
||||
Drug Name |
SR-26831
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Rheumatoid arthritis [ICD9: 710-719, 714; ICD10:M05-M06] | Terminated | [544831] | ||
Company |
Sanofi
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H23ClNO3S+
|
||||
Canonical SMILES |
c1(sc2c(c1)C[N+](Cc1c(Cl)cccc1)(CC2)[O-])OC(=O)C(C)(C)C
|
||||
CAS Number |
CAS 139995-67-8
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Leukocyte elastase | Target Info | Modulator | [528753] | |
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
C-MYB transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.